MedPath

晖致(海南)投资有限公司

Ownership
-
Established
2022-04-11
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Telmisartan and Amlodipine Tablets(Ⅱ)

Product Name
替米沙坦氨氯地平片(Ⅱ)
Approval Number
国药准字H20254435
Approval Date
Jun 3, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.